Navigation Links
Small Changes in Two Genes May Trigger Breast Cancer
Date:5/13/2010

Testing for genetic variations might reveal women most at risk, researchers say

THURSDAY, May 13 (HealthDay News) -- Slight changes in the expression of two common genes trigger cellular changes that can lead to breast cancer, a new study finds.

The researchers adjusted the expression of the genes -- estrogen receptor alpha and p53 -- in mice but said the tweaks they made in the rodents likely mimic natural variations of the two genes in women.

"It was believed that both of these genes only act once breast cancer had developed," lead investigator Dr. Priscilla A. Furth, a professor of oncology and medicine at Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, said in a news release. She added that p53 mutations are found in many cancers, including breast cancer, and that a majority of breast cancer patients have over-expression of this common estrogen receptor.

"What wasn't known is that different levels of expression of these genes can help launch the cellular changes that lead to breast cancer. That suggests that testing women for their own variations in these genes might potentially give us a clue as to which women are at higher risk for development of breast cancer," she said.

In this study, Furth and colleagues developed mice that lacked one copy of the p53 gene (mice and humans have two copies of this gene, one from each parent). This gene regulates cell growth and is a powerful tumor suppressor. Changes in p53 are seen in 30 percent to 40 percent of breast cancer cases.

In another group of mice, the researchers boosted expression of estrogen receptor alpha by twofold, a level of increase sometimes seen in women. Nearly 70 percent of breast cancer patients have estrogen receptor-positive breast cancer, they noted.

Both groups of mice showed significant precancerous changes in breast tissue. Those changes were even more evident in mice that had one p53 gene as well as twice as much estrogen receptor expression.

"Normal breast tissue functioning requires a balance of cell growth and cell death, and in this study we found that both deregulated estrogen receptor function and p53 expression independently, and in combination, altering this balance and transforming cells," Furth said.

"These are not the only two molecules that are responsible for breast cancer development, but they are important and they can potentially provide us with an early warning or even with prevention strategies," she added.

The study was published online May 13 in the journal Cancer Research.

More information

The U.S. Centers for Disease Control and Prevention has more about breast cancer.



-- Robert Preidt



SOURCE: Georgetown University Medical Center, news release, May 13, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. IPC The Hospitalist Company, Inc. to Present at Deutsche Bank 2010 Small and Mid Cap Conference
2. Omnetics Nano-to-Flex Connectors Solve Big Problems in Small Spaces
3. Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses
4. Even a Small Dietary Reduction in Salt Could Mean Fewer Heart Attacks, Strokes and Deaths
5. Small Cuts in Salt Intake Spur Big Drops in Heart Trouble
6. NSBA 2009 Year-End Economic Report: Small Businesses Still Struggling
7. NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy
8. Union Tax Deal a Slap in the Face to Small Business
9. Smaller Airports May Endanger Health
10. New Disability Income Insurance Options Provide More Choice for Californias Small Business Owners
11. Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing and ... compliance with FDA rules. , The FDA has issued two draft guidances that ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... September 21, 2017 , ... Japanese Zen artist couple, ... Revolution” on 6th, 7th and 8th October at Miranda Kuo Gallery on Lower East ... pieces, such as Zen Kodo mat. Wanderlust , one of the largest US ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... serving communities in northern Alabama and Georgia, is embarking on an extended charity ... utilizing modern early detection methods. , US Breast Cancer statistics show that ...
(Date:9/20/2017)... ... September 20, 2017 , ... Collins Concrete ... for clients that rely on safety and cleanliness. This unique flooring system uses ... has been used for centuries for its antimicrobial properties. Unlike antibiotics, which kill ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Medicine Technology: